课题基金 / 基金详情

Application of TAL effectors to control gene expression in human cells

Application of TAL effectors to control gene expression in human cells
TAL效应器在控制人体细胞基因表达中的应用
批准号:
215015307
负责人:
Professor Dr. Sven-Erik Behrens
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2012
资助国家:
德国
项目状态:
已结题
起止时间:
2011-12-31 至 2016-12-31

项目摘要

项目成果

Professor Dr. Sven-Erik Behrens的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
TAL effectors (TALs) from plant-pathogenic bacteria are proteins that act as transcription factors in plant cells and employ a unique DNA-binding domain with programmable specificity. As recently shown by others and us, TAL derivatives also function in human cells and may represent excellent tools for the control of human gene expression. The proposed project aims at optimizing TALs as gene switches in human cells. As targets of TALs we chose elements of medical importance, i.e., the promoter of the interferon beta (IFN- β) gene and the provirus of human immunodeficiency virus (HIV). We will focus on optimizing the parameters that govern TAL efficiency and examine positional effects as well as the effects of TALs on DNA modifications and chromatin structure. Moreover, TALs with different transcription activator and nuclease domains will be tested. We will then analyze the effects of TALs on IFN-β and HIV gene expression. Testing various human virus systems, the consequences of artificial IFN-β expression on the cellular antiviral state will be investigated and the interferon stimulated gene (ISG) expression profiles of cells with viral- and TAL-mediated IFN-β expression will be determined. Targeting the HIV provirus, we aim at applying TALs for activation of HIV from latency and for editing of the provirus, respectively. The goal is to develop the TAL technology for routine applications in human cells and, specifically, for the control of viral infections.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study.
通过定制 TAL 效应器 (TALE) 进行针对患者的特异性 HIV-1 激活,这是一项原理研究证明
DOI: 10.1016/j.virol.2015.09.018
发表时间: 2015
期刊: Virology
影响因子: 3.7
作者: [Geissler R, Hauber I, Funk N, Richter AK, Behrens M, Renner I, Chemnitz J, Hofmann- Sieber H, Baum H, van Lunzen J, Boch J, Hauber J, Behrens SE]
通讯作者: Behrens SE
Functional characterization of cellular RNA-binding proteins that support Flavivirus replication
  • 批准号:
    319589351
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2016
  • 负责人:
    Professor Dr. Sven-Erik Behrens
  • 依托单位:
Effect of viral infections on the activity of cellular RNAs
  • 批准号:
    47325587
  • 项目类别:
    Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2007
  • 负责人:
    Professor Dr. Sven-Erik Behrens
  • 依托单位:
Characterization of host proteins that participate in the replication of hepatitis C virus (HCV)
  • 批准号:
    32153108
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2006
  • 负责人:
    Professor Dr. Sven-Erik Behrens
  • 依托单位:
Efficient small nucleic acids to combat human respiratory viruses
  • 批准号:
    462028519
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Professor Dr. Sven-Erik Behrens
  • 依托单位:
国内基金
海外基金
TAL1介导急性T淋巴细胞白血病糖皮质激素耐药的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
Non-TAL效应子NUDX4通过Nudix水解酶活性调控水稻白叶枯病菌致病性的分子机制
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    郭宝佃
  • 依托单位:
S1P-S1PR3激活RAS信号促进TAL1+亚型T-ALL进展的机制研究
  • 批准号:
    82270160
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    邹琳
  • 依托单位:
TAL1复合体上调S1PR3激活NOTCH1信号促进T-ALL发生发展的机制研究
  • 批准号:
    82070167
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    邹琳
  • 依托单位: